A Phase 1 Study To Evaluate The Pharmacokinetics Of Ag-013736 In Subjects With Impaired Hepatic Function.
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2016
At a glance
- Drugs Axitinib (Primary)
- Indications Colorectal cancer; Liver cancer; Renal cancer; Solid tumours; Thyroid cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 12 Mar 2016 Results assessing pharmacokinetics from this other trial presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 21 Nov 2008 Actual start date changed from June 2008 to May 2008, actual end date reported as October 2008 by ClinicalTrials.gov.
- 21 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.